For Big Biotech It is Never Enough

Oh, the whining. Massachusetts has funded and permitted human SCNT, but it forbids the buying and selling of human eggs for biological research. This has apparently brought research into human cloning to a halt because women aren’t particularly interested in risking their lives, fecundity, and health so that some university or corporate (today they often wear both hats at once) scientist can strike it rich. The answer? Pay women to risk their lives and health. From the version of the story in the Harvard Crimson:

Assistant Professor of Molecular and Cellular Biology Kevin C. Eggan expressed frustration at a major stem cell conference on Tuesday about a Massachussetts law that creates roadblocks to medical research.

Eggan lamented a state policy that limits access to human eggs by forbidding researchers from compensating women for egg donation. Since its inception in 2004, the Harvard Stem Cell Institute has not obtained a single egg from an eligible donor.

Eggan left town immediately after the conference ended yesterday and could not be reached for additional comment.

B.D. Colen, Harvard’s senior communications officer for University science, said Eggan blamed an unfriendly legal climate at the state and federal levels for the Institute’s lack of experimental findings. He added that Eggan noted women can receive compensation for eggs donated to treat infertility, but not for use in medical research.

“Despite an advertising campaign to find donors, we have yet to have a woman donate an egg to our cause,” Eggan said, according to The Boston Globe.

Does the professor have a daughter or wife? Has he urged them to donate?

This story further illustrates the blank check mentality—both financially and ethically—that permeates Big Biotech. As to the disparity between research and IVF clinics: The answer isn’t to permit buying and selling of eggs in research, it is to ban buying and selling of eggs for use in the very profitable fertility industry.

Dear Reader,

Can I be direct with you?

War abroad. Socialists on the rise. AI upending human life. Endless uproar online. The modern attention economy doesn’t want readers — it wants users enslaved to the tyranny of the present.

First Things is the antidote: literary excellence, timeless truths, and a fixed point of reference in a culture that has lost its bearings.

But we can’t do it without readers like you.

Our goal: Raise $150,000 by November 1 to sustain First Things in the year ahead.


Your gift anchors readers in the permanent things.

Make your Fall Campaign gift now using the button below.

GIVE NOW

If you have any questions or would like more information, please contact Giovanni Del Piero, Director of the Editor’s Circle, at gdelpiero@firstthings.com or 212-627-1985.

Next
YOU MIGHT ALSO LIKE

The Church in the Age of Therapy

Matthew Loftus

In 1966, Philip Rieff wrote in The Triumph of the Therapeutic that “Religious man was born to…

Canada’s Deadliest Blind Spot

Anna Farrow

On September 20, the Daily Mail ran a story with the provocative headline, “Our 83-year-old Christian grandmother…

The Faithful Joy of Dolly Parton and Fulton Sheen

Mike Aquilina

Dolly Parton and Fulton Sheen seem to have had little in common. She favored rhinestones; he wore…